SCHEMBL6174640

SCHEMBL6174640

CCOc1cnccc1C(C)C1NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.37
RXFP1 Q9HBX9 2/20 0.37
LMNA P02545 3/20 0.34
PTGS1 P23219 1/20 0.34
PTGS2 P35354 1/20 0.34
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
LARS1 Q9P2J5 1/20 0.32
CCR9 P51686 1/20 0.31
HRH4 Q9H3N8 1/20 0.31
SMN1; SMN2 Q16637 2/20 0.30
ALDH1A1 P00352 1/20 0.30
KMT2A Q03164 1/20 0.30
MAPK1 P28482 1/20 0.30
HTT P42858 1/20 0.30
CMA1 P23946 1/20 0.30
TRPV3 Q8NET8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174450 0.90 IGF1R (0.38) IGF1RRXFP1LMNA
SCHEMBL6175260 0.88 IGF1R (0.39) IGF1RLMNAPTGS2HRH4SMN1; SMN2
SCHEMBL6175175 0.87 IGF1R (0.36) IGF1RLMNAPTGS2SMN1; SMN2MAPK1
SCHEMBL6174658 0.85 RXFP1 (0.34) IGF1RRXFP1LMNACA12CA1
SCHEMBL6171408 0.85 IGF1R (0.35) IGF1RLMNAPTGS2LARS1SMN1; SMN2
SCHEMBL6173330 0.84 IGF1R (0.40) IGF1RLMNASMN1; SMN2MAPK1HTT
SCHEMBL6175529 0.83 IGF1R (0.37) IGF1RLMNAHRH4
SCHEMBL6176021 0.83 IGF1R (0.34) IGF1RRXFP1LMNAPTGS1PTGS2
SCHEMBL6175297 0.82 LMNA (0.39) IGF1RLMNAPTGS2SMN1; SMN2MAPK1
SCHEMBL6174116 0.81 IGF1R (0.33) IGF1RLMNAPTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed